Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06569537 · ClinicalTrials.gov registry record · Phase 4
Comparison of Compounded Topical Anesthetics
A Phase 4 study of Procedural Pain, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06569537: Recruiting Phase 4 study of Procedural Pain, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06569537 is a Phase 4 study of Procedural Pain that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 64 participants, above the 54-participant average among 9 other Procedural Pain trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06569537, a Phase 4 study of Procedural Pain, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.
Primary Outcome
The NPRS pain scale is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.
Conditions Studied
Interventions
- DRUG Lidocaine topical
- DRUG BLT
Study Locations (1)
New Hampshire
- Dartmouth Hitchcock Dermatology Clinic - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2026-01 |
| Phase | Phase 4 |
What NCT06569537 shows while recruiting
NCT06569537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, above the 54-participant average among 9 other Procedural Pain trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Procedural Pain appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine topical is the first listed.
NCT06569537 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06569537 about?
NCT06569537 is a clinical study titled "Comparison of Compounded Topical Anesthetics". The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.
What is the current status of trial NCT06569537?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2024-10-22. Estimated completion is 2026-01.
What conditions does trial NCT06569537 study?
This clinical trial studies the following conditions: Procedural Pain.
What interventions are being tested in trial NCT06569537?
The interventions under investigation include: Lidocaine topical (DRUG), BLT (DRUG).
Who is sponsoring clinical trial NCT06569537?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06569537 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Procedural Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06569537's enrollment target sits among peer trials
64 3rd of 9 higher than 7 of 9 other Procedural Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Procedural Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy
RECRUITING · Phase 4
-
Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants
COMPLETED · Phase 4
-
Cervical Preparation for Same-Day Dilation & Evacuation
RECRUITING · NA
-
Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol
RECRUITING · NA
-
Oral Surgery Virtual Reality Glasses Study
RECRUITING · NA
-
Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI